Literature DB >> 26873918

Fulminant zygomycosis of graft liver following liver transplantation.

Pulkit Sethi1, Dinesh Balakrishnan1, Sudhindran Surendran1, Zubair Umer Mohamed2.   

Abstract

A 44-year-old man with hepatitis B virus (HBV)-related cirrhosis underwent living donor liver transplantation at our institute. Induction of immunosuppression was achieved with basiliximab, due to deranged renal function, and maintained with prednisolone, tacrolimus and mycophenolate mofetil. The intraoperative and immediate postoperative periods were fairly uneventful. A duplex scan, taken during the third week post-transplantation due to sudden rise in liver enzymes, revealed multifocal hypoechoic lesions in the graft liver with normal Doppler parameters. Multidetecor computed tomography (MDCT) showed multiple hypodense vessel-sparing lesions in the graft liver. Cultures from the aspirate grew filamentous fungi identified as Basidiobolus ranarum species. Despite multiple broad spectrum antifungal infusions including liposomal amphotericin, itraconazole, caspofungin and posaconazole, serial sonography showed the hepatic lesions increasing in size, and involving segments V, VI and VII. The patient developed severe liver dysfunction ultimately progressing to sepsis, multiorgan dysfunction and death. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26873918      PMCID: PMC5483582          DOI: 10.1136/bcr-2015-214097

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  5 in total

Review 1.  Gastrointestinal zygomycotic infection caused by Basidiobolus ranarum: case report and review.

Authors:  D M Zavasky; W Samowitz; T Loftus; H Segal; K Carroll
Journal:  Clin Infect Dis       Date:  1999-06       Impact factor: 9.079

2.  Invasive gastrointestinal Basidiobolus ranarum infection in an immunocompetent child.

Authors:  Noshin Wasim Yusuf; Hasan M Assaf; Nathaniel A Rotowa
Journal:  Pediatr Infect Dis J       Date:  2003-03       Impact factor: 2.129

Review 3.  Emergence of gastrointestinal basidiobolomycosis in the United States, with a review of worldwide cases.

Authors:  Holenarasipur R Vikram; Jerry D Smilack; Jonathan A Leighton; Michael D Crowell; Giovanni De Petris
Journal:  Clin Infect Dis       Date:  2012-03-22       Impact factor: 9.079

4.  Concurrent subcutaneous and visceral basidiobolomycosis in a renal transplant patient.

Authors:  C Choonhakarn; K Inthraburan
Journal:  Clin Exp Dermatol       Date:  2004-07       Impact factor: 3.470

5.  Disseminated basidiobolomycosis in an immunocompetent woman.

Authors:  Caterina Bigliazzi; Venerino Poletti; Davide Dell'Amore; Luca Saragoni; Thomas V Colby
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

  5 in total
  3 in total

Review 1.  Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors.

Authors:  Xin Li; Susanna Kp Lau; Patrick Cy Woo
Journal:  Exp Biol Med (Maywood)       Date:  2020-07-08

2.  Disseminated angioinvasive basidiobolomycosis with a favourable outcome.

Authors:  Fatehi Elzein; Mohammed Mursi; Ahmed M Albarrag; Abdullah Alfiaar; Abdulaziz Alzahrani
Journal:  Med Mycol Case Rep       Date:  2018-08-07

3.  Subcutaneous Granulomatous Inflammation due to Basidiobolomycosis: Case Reports of 3 Patients in Buruli Ulcer Endemic Areas in Benin.

Authors:  Luc V C Brun; Jean Jacques Roux; Ghislain E Sopoh; Julia Aguiar; Miriam Eddyani; Wayne M Meyers; Dirk Stubbe; Marie T Akele Akpo; Françoise Portaels; Bouke C de Jong
Journal:  Case Rep Pathol       Date:  2018-01-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.